- Open Access
Carbon monoxide affects electrical and contractile activity of rat myocardium
© Abramochkin et al; licensee BioMed Central Ltd. 2011
- Received: 8 March 2011
- Accepted: 15 June 2011
- Published: 15 June 2011
Carbon monoxide (CO) is a toxic gas, which also acts in the organism as a neurotransmitter. It is generated as a by-product of heme breakdown catalyzed by heme oxygenase. We have investigated changes in electrical and contractile activity of isolated rat atrial and ventricular myocardium preparations under the influence of CO.
Standard microelectrode technique was used for intracellular registration of electrical activity in isolated preparations of atrial and ventricular myocardium. Contractions of atrial myocardial stripes were registered via force transducer.
CO (10-4 - 10-3 M) caused prominent decrease of action potential duration (APD) in working atrial myocardium as well as significant acceleration of sinus rhythm. In addition CO reduced force of contractions and other parameters of contractile activity. Inhibitor of heme oxygenase zinc protoporphyrin IX exerts opposite effects: prolongation of action potential, reduction of sinus rhythm rate and enhancement of contractile function. Therefore, endogenous CO, which may be generated in the heart due to the presence of active heme oxygenase, is likely to exert the same effects as exogenous CO applied to the perfusing medium. In ventricular myocardium preparations exogenous CO also induced shortening of action potential, while zinc protoporphyrin IX produced the opposite effect.
Thus, endogenous or exogenous carbon monoxide may act as an important regulator of electrical and contractile cardiac activity.
- Heme Oxygenase
- Action Potential Duration
- Contractile Activity
- Ventricular Myocardium
- Sinoatrial Node
During the last twenty years two toxic gases: carbon monoxide (CO) and hydrogen sulfide (H2S) were recognized as important regulatory compounds which are synthesized endogenously in different tissues of the organism . Along with nitric oxide (NO) CO and H2S represent a class of gaseous transmitters. Cardiovascular effects of NO, CO and H2S have been extensively studied. For instance, all three gases act as potent vasodilators though NO and CO relax vascular smooth muscle cells in a few orders of magnitude lower concentrations than H2S . The effect of gaseous mediators on heart functioning has received less attention than their effect on blood vessels. NO donors produce positive inotropic effect in low concentrations, while higher concentrations may cause suppression of contractile activity . These compounds also accelerate the sinoatrial node rhythm and therefore increase the heart rate . Such effects of NO are mediated by modulation of numerous ionic currents (ICa, IKs, IK1, If and others) via either activation of soluble guanylyl cyclase with subsequent increase of intracellular cGMP content and cGMP-independent mechanisms (S-nitrosylation and direct effects on G proteins) . In contrast to NO, H2S exhibits negative inotropic activity in all examined concentrations , it also reduces action potential duration (APD) in rat atrial myocardium . Cardioprotective effects of all three gases against ischemic injury have been described in several studies [6–8].
Cardiotropic effects of CO have been sparsely investigated and the data are quite controversial. While some authors report negative inotropic effect of CO , others describe positive inotropy in isolated rat heart . Nothing is known about possible CO-induced changes of cardiac electrical activity. Nevertheless, investigation of cardiotropic effects of CO is interesting especially in the light of cardioprotective action of CO against ischemia-reperfusion injury shown in several studies [10, 11]. Therefore, the aim of the present study was to explore effects of exogenous and endogenous CO on the electrical and contractile activity of isolated rat myocardium preparation.
The investigation conformed with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996), and the experimental protocol was approved by the Bioethics Committee of Moscow State University and the Animal Care and Use Committee of Kazan State Medical University.
Male Wistar rats (n = 38) weighing 280-320 g were decapitated using a guillotine for small animals (OpenScience, Moscow, Russia), the chest was opened and the heart rapidly excised and immersed in a physiological solution containing (mM): NaCl, 130.0; KCl, 5.6; NaH2PO4, 0.6; MgCl2, 1.1; CaCl2, 1.8; NaHCO3, 20.0 and glucose, 11.0, bubbled with carbogen (95% O2-5% CO2), with pH 7.4 ± 0.1.
Intracellular recordings of APs in isolated right atrium and right ventricular wall of rats
The right atrial preparation, including the auricle, the crista terminalis, the intercaval region and the sinoatrial node, was isolated and pinned to the bottom of an experimental chamber (3 ml) supplied with a physiological solution at 10 ml min-1 (37.5°C). After 2 h of equilibration, transmembrane potentials were recorded with glass microelectrodes (20-30 MΩ) filled with 3 M KCl. The signal was digitized and analyzed using specific software (DISoft, Moscow, Russia; Synaptosoft, Decatur, GA, USA). Spontaneously occurring action potentials (APs) were recorded from the endocardial surface of the auricle. In some experiments the sinoatrial node was removed and the preparation was paced (6 Hz) via silver teflon-coated electrodes. Stable impalements were maintained during the entire period action of the drugs. Changes in the cycle length (CL) and the AP duration to 50 (APD50) and 90% of repolarization (APD90) were analyzed. The similar experiments were performed using isolated right ventricular wall preparations paced with a frequency of 6 Hz. APs were also recorded from subendocardial layers.
Registration of contractile activity
The stripes of working myocardium of 4-6 mm length and 1 mm diameter were excised from the right atrium preparations and mounted in a special perfusion chamber (ADInstruments, Sydney, Australia). During the experiment it was stimulated with a frequency of 0.1 Hz via pair of silver electrodes. The force of contractions was registered using a mechanotransducer MLT 050/D (ADInstruments, Sydney, Australia). The data were analyzed with Chart v.5.0 (ADInstruments, Sydney, Australia) software. The amplitude of contractions was determined as well as maximal velocity of contraction (MVC) and relaxation (MVR).
CO of 99% purity was obtained from NIIKM (Moscow, Russia). The inhibitor of heme oxygenase (HO) zinc protoporphyrin-IX (ZnPP) was purchased from Sigma (St Louis, MO, USA).
The stock solution of CO was prepared immediately before its usage in the experiment by bubbling of physiological solution with CO. Since the water solubility of CO is 26.91 mg/l, the concentration of CO in the stock solution was 0.96 mM . To simplify the presentation of data we considered it to be 1 mM approximately. During the experiment the stock solution was used to prepare physiological solutions with different concentrations of CO which were applied to the experimental chamber. The stock solution of ZnPP was prepared as described by Vreman et al . Experiments with ZnPP were carried out at a very low or zero ambient light due to the photo reactivity of compound .
All results in the text, tables and figures are expressed as means ± S.E.M. for n experiments. All samples were tested with Kolmogorov-Smirnov normality test. Each sample differed significantly from the normal distribution (P < 0.05 for every sample), so we used non-parametric tests for analysis. The effects of CO or ZnPP on electrophysiological and mechanical parameters were compared with respective basal values of these parameters by Wilcoxon signed rank test.
Effects of exogenous CO on electrical activity of atrial and ventricular myocardium
It is well known that increase of the beating rate per se leads to the reduction of APD. Therefore, shortening of AP under the action of CO in spontaneously beating preparations may be due to increase of sinoatrial node rate. To check this possibility we have performed a series of experiments with paced atrial preparations. In these experiments CO reduced APD50 and APD90 as much as in spontaneously beating preparations (Figure 2b).
In working myocardium of isolated right ventricular wall CO also induced marked shortening of APs (Figure 2c).
Effects of CO on contractile activity of atrial myocardium
Effects of HO inhibitor ZnPP
In the present study we provide the first to our knowledge evidence that CO significantly affects electrical activity of atrial and ventricular myocardium. We demonstrate the striking difference between action of CO in the working myocardium, where it produces negative effects: shortening of APs and suppression of contractile activity, and sinoatrial node. Unlike H2S , CO accelerates the sinoatrial rhythm. It seems that signal transduction pathways, which are activated by CO, may differ in working and sinoatrial cardiomyocytes. For example, variations in enzymes, which synthesize and degrade second messengers like cAMP and cGMP, may be present in these types of cardiac cells. Further investigation of signal transduction pathways mediating cardiotropic effects of CO will help to reveal the mechanisms of such opposite effects of CO in working and pacemaker myocardium.
The described negative inotropic effect of CO conforms to the findings of Liu et al that demonstrated suppression of rat papillary muscles contractions under 1 mM CO . However, our data are in controversy with results of Musameh et al showing the positive inotropy of CO associated with decrease of heart rate in the isolated rat Langendorf-perfused heart preparation . The latter discrepancy might be at least partly due to the difference in the method of CO application to the perfusing solution. Like Liu et al we used the stock solution directly saturated with CO, while Musameh et al used special CO releasing molecules that may possibly exert some accessory effects. Mechanisms of both negative and positive effects of CO need special investigation. Negative effects on APD and contractile parameters may be partly explained by suppression of ICaL by CO , although this assumption should be tested further. Unfortunately, blockers of calcium channels drastically modify electric activity of myocardium. For example, nifedepine produces extremely large shortening of APs and slowing of sinus rhythm if used in concentration sufficient for full block of ICaL. Therefore, effects of these compounds will mask possible action of CO. So, we guess that the only way to prove this assumption is to perform appropriate patch-clamp experiments.
Although exogenous CO causes prominent changes in the electrical and mechanical activity of myocardium, it doesn't testify to the physiological role of CO as a regulator of cardiac performance. To act as a cardioregulator CO should be synthesized in the myocardium or in the close proximity to it, because it is quickly scavenged in the organism by hemoglobin and other heme proteins . CO is generated in the organism as a by-product of heme breakdown catalyzed by HOs: inducible HO-1 and constitutively expressed HO-2. In normal conditions expression of HO-1 is detected in heart vascular wall, but not in cardiomyocytes . However, HO-1 protein expression may be significantly up-regulated by pathological stimuli, such as myocardial infarction , or hypoxia . HO-2 is expressed in the atrial and ventricular myocardium  as well as in intracardiac neurons . Thus, heart possesses potential sources of endogenous CO. Experiments with ZnPP, which inhibits both isoforms of HO, clearly indicate that inhibition of endogenous CO production leads to significant changes in electrical and contractile activity of myocardium which are opposite to the effects of exogenous CO. Therefore, endogenous CO seems to be synthesized in the myocardium in normal conditions and act similarly to the exogenous CO, although it is still not clear if cardiac CO is synthesized in the cardiomyocytes by HO-2 or in the coronary vessels by HO-1.
Unfortunately, the present study has several limitations. First, the concentrations of CO sufficient for the significant alteration of cardiac electrical and mechanical activity in our experiments are strikingly high. CO is transported by blood in the form of carbonmonoxy-hemoglobin A (COHb). Estimated physiological concentrations of CO in tissues are rather low, in the nanomolar range if based on normal levels of COHb of 1 to 2% . However, the correlation between COHb and tissue concentrations of CO is questionable, since CO generated in living cells would first be scavenged in the cytosol by heme proteins reaching the bloodstream . In fact, local concentrations of CO might be as high as concentrations used in our experiments. The significant effects of ZnPP validate this assumption, although the possibility of non-specific ZnPP action can't be excluded. However, while high concentrations of ZnPP (10-4 M) are really able to inhibit guanylyl cyclase  and calcium channels , 10-5 M ZnPP is considered as a quite selective HO inhibitor . Moreover, inhibition of L-type calcium current leads to shortening of APs, while ZnPP induces increase in APD.
Thus, we have shown that both exogenous and endogenous CO substantially alters electrical and contractile activity of rat heart by decreasing the APD in working atrial and ventricular myocardium, increasing the sinoatrial node beating rate and suppressing the contractile activity of atrial myocardium.
This study was supported by Russian Fund of Basic Research (09-04-00748) and President Grant for Leading Scientific Schools (NS-5250.2010.4).
- Li L, Hsu A, Moore PK: Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulfide in the cardiovascular system and inflammation - a tale of three gases!. Pharmacol Ther. 2009, 123: 386-400. 10.1016/j.pharmthera.2009.05.005.View ArticlePubMedGoogle Scholar
- Kojda G, Kottenberg K: Regulation of basal myocardial function by NO. Cardiovasc Res. 1999, 41: 514-523. 10.1016/S0008-6363(98)00314-9.View ArticlePubMedGoogle Scholar
- Tamargo J, Caballero R, Gomez R, Delpon E: Cardiac electrophysiological effects of nitric oxide. Cardiovasc Res. 2010, 87: 593-600. 10.1093/cvr/cvq214.View ArticlePubMedGoogle Scholar
- Geng B, Yang J, Qi Y: H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun. 2004, 313: 362-368. 10.1016/j.bbrc.2003.11.130.View ArticlePubMedGoogle Scholar
- Abramochkin DV, Moiseenko LS, Kuzmin VS: The effect of hydrogen sulfide on electrical activity of rat atrial myocardium. Bull Exp Biol Med. 2009, 147: 683-686. 10.1007/s10517-009-0607-y.View ArticlePubMedGoogle Scholar
- Lochner A, Marais E, Genade S, Moolman JA: Nitric oxide: a trigger for classic preconditioning?. Am J Physiol. 2000, 279: 2752-2765.Google Scholar
- Musameh MD, Fuller BJ, Mann BE, Green CJ, Motterlini R: Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart. Br J Pharmacol. 2006, 149: 1104-1112.PubMed CentralView ArticlePubMedGoogle Scholar
- Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS: Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol. 2006, 40: 119-130. 10.1016/j.yjmcc.2005.10.003.View ArticlePubMedGoogle Scholar
- Liu H, Song D, Lee SS: Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol. 2001, 280: G68-G74.PubMedGoogle Scholar
- Clark JE, Naughton P, Shurey S: Cardioprotective actions by a water-soluble carbon monoxidereleasing molecule. Circ Res. 2003, 93: e2-e8. 10.1161/01.RES.0000084381.86567.08.View ArticlePubMedGoogle Scholar
- Guo Y, Stein AB, Wu WJ: Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol. 2004, 286: H1649-H1653. 10.1152/ajpheart.00971.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Zufall F, Leinders-Zufall T: Identification of a long-lasting form of odor adaptation that depends on the carbon Monoxide/cGMP second-messenger system. J Neurosci. 1997, 17: 2703-2712.PubMedGoogle Scholar
- Vreman HJ, Rodgers PA, Stevenson DK: Zinc protoporphyrin administration for suppression of increased bilirubin production by latrogenic hemolysis in rhesus neonates. J Pediatr. 1990, 117: 292-297. 10.1016/S0022-3476(05)80550-5.View ArticlePubMedGoogle Scholar
- Suematsu M, Goda N, Sano T: Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest. 1995, 96: 2431-2437. 10.1172/JCI118300.PubMed CentralView ArticlePubMedGoogle Scholar
- Uemura K, Adachi-Akahane S, Shintani-Ishida K, Yoshida K: Carbon monoxide protects cardiomyogenic cells against ischemic death through L-type Ca2+ channel inhibition. Biochem Biophys Res Commun. 2005, 334: 661-668. 10.1016/j.bbrc.2005.06.142.View ArticlePubMedGoogle Scholar
- Wu L, Wang R: Carbon monoxide: Endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev. 2005, 57: 585-630. 10.1124/pr.57.4.3.View ArticlePubMedGoogle Scholar
- Lakkisto P, Palojoki E, Backlund T: Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol. 2002, 34: 1357-1365. 10.1006/jmcc.2002.2094.View ArticlePubMedGoogle Scholar
- Grilli A, De Lutiis MA, Patruno A: Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Ann Clin Lab Sci. 2003, 33: 208-215.PubMedGoogle Scholar
- Ewing JF, Raju VS, Maines MD: Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3':5'-guanosine monophosphate. J Pharmacol Exp Ther. 1994, 271: 408-414.PubMedGoogle Scholar
- Hassal CJ, Hoyle CH: Heme oxygenase-2 and nitric oxide synthase in guinea-pig intracardiac neurons. Neuroreport. 1997, 8: 1043-1046. 10.1097/00001756-199703030-00045.View ArticleGoogle Scholar
- Piantadosi CA: Biological chemistry of carbon monoxide. Antioxid Redox Signal. 2002, 4: 259-270. 10.1089/152308602753666316.View ArticlePubMedGoogle Scholar
- Maines MD: The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997, 37: 517-554. 10.1146/annurev.pharmtox.37.1.517.View ArticlePubMedGoogle Scholar
- Kinobe RT, Dercho RA, Nakatsu K: Inhibitors of the heme oxygenase - carbon monoxide system: on the doorstep of the clinic?. Can J Physiol Pharmacol. 2008, 86: 577-599. 10.1139/Y08-066.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.